COAG

Conviction 100HealthcareScan · Thu, Jun 25, 2026

COAG$27.88-3.04%

ResistanceSupportVol 14Insider buy

Vol MA14 416.81K

May 1May 12May 22Jun 3Jun 15Jun 25

Hemab Therapeutics Holdings, Inc.Biotechnologywww.hemab.com ↗

Price27.88

Change-3.04%

Gap-1.27%

Rel volume4.84×

Avg volume336.61K

Avg $ vol9.34M

SMA 2027.09

SMA 50—

SMA 200—

Price vs 50—

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 32.07

RSI (14)48

MACD hist0.45

MACD cross—

Stoch %K / %D50 / 59

ADX (14)10

+DI / −DI20 / 15

RSI divergenceBullish

MACD divergence—

ATR %+9.49%

ADR %8.81%

52w high34.00

52w low24.98

From 52w high-18.00%

Above 52w low+11.61%

New 52w highNo

SqueezeOn · 18d

Bollinger width25.55%

%B0.61

Donchian pos49.84%

Donchian high31.98

Donchian low23.81

AVWAP (52w high)28.60

vs AVWAP high-2.53%

AVWAP (52w low)27.44

vs AVWAP low+1.60%

OBV trendFlat

Chaikin MF (20)0.07

Today vs 20d4.84×

Avg vol (14d)416.81K

Avg vol (20d)336.61K

Avg $ vol (20d)9.34M

Market cap1.3B

RS 3m (vs SPY)—

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank31.1

1 week+5.41%

1 month+0.14%

3 months—

6 months—

1 year—

YTD-18.00%

P/E—

P/B-6.56

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current12.85

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target41.40

Target upside48.49%

Analyst ratingBuy

Institutional—

Ent. value1.25B

Revenue—

Net income-22.69M

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out46.71M

Employees—

ListedFri, May 1, 2026

Free float15.97M

Float %40.7%

Short interest1.03M

Days to cover6.5d

Short volume91.2%

Squeeze score73 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$23.98

Last surprise—

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank31.1 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in COAG

All disclosures →

No recent disclosed trades by Congress in COAG. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in COAG · 7 buys

Insider	Side	Shares	Value	Traded	Filed
RA Capital Healthcare Fund LP 10% owner · Common Stock · 2026-05-20	Buy	996	$25K	2026-05-20	2026-05-21
RA CAPITAL MANAGEMENT, L.P. 10% owner · Common Stock · 2026-05-20	Buy	996	$25K	2026-05-20	2026-05-21
Kolchinsky Peter 10% owner · Common Stock · 2026-05-20	Buy	996	$25K	2026-05-20	2026-05-21
Shah Rajeev M. 10% owner · Common Stock · 2026-05-20	Buy	996	$25K	2026-05-20	2026-05-21
RA Capital Healthcare Fund LP 10% owner · Common Stock · 2026-05-19	Other	—	—	2026-05-19	2026-05-21
Shah Rajeev M. 10% owner · Common Stock · 2026-05-19	Buy	3.8K	$95K	2026-05-19	2026-05-21
RA Capital Healthcare Fund LP 10% owner · Common Stock · 2026-05-19	Buy	3.8K	$95K	2026-05-19	2026-05-21
RA CAPITAL MANAGEMENT, L.P. 10% owner · Common Stock · 2026-05-19	Buy	3.8K	$95K	2026-05-19	2026-05-21
RA CAPITAL MANAGEMENT, L.P. 10% owner · Common Stock · 2026-05-19	Other	—	—	2026-05-19	2026-05-21
Shah Rajeev M. 10% owner · Common Stock · 2026-05-19	Other	—	—	2026-05-19	2026-05-21

SEC filings

EDGAR filings in COAG

EDGAR →

No recent SEC filings on file for COAG.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.